Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
May standardize CSX diagnosis around microvascular dysfunction; leaves open prospective validation before practice or trial adoption.
G. A. Lanza (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: